These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35099254)

  • 1. The effect of long-term hypogonadism on body composition and morphometry of aged male Wistar rats.
    Borbélyová V; Šarayová V; Renczés E; Čonka J; Janko J; Šebeková K; Štefíková K; Ostatníková D; Celec P
    Physiol Res; 2021 Dec; 70(S3):S357-S367. PubMed ID: 35099254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
    Donner DG; Elliott GE; Beck BR; Forwood MR; Du Toit EF
    Osteoporos Int; 2016 Mar; 27(3):1073-1082. PubMed ID: 26438310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does long-term androgen deficiency lead to metabolic syndrome in middle-aged rats?
    Borbélyová V; Domonkos E; Bábíčková J; Tóthová Ľ; Kačmárová M; Uličná O; Ostatníková D; Hodosy J; Celec P
    Exp Gerontol; 2017 Nov; 98():38-46. PubMed ID: 28807822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism.
    Zacharin MR; Pua J; Kanumakala S
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):691-5. PubMed ID: 12780744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight, and morphometric indices for bone evaluation in an animal model (the orchidectomized rat) of male osteoporosis.
    Libouban H; Moreau MF; Legrand E; Baslé MF; Audran M; Chappard D
    Calcif Tissue Int; 2001 Jan; 68(1):31-7. PubMed ID: 12037621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of biochemical hypogonadism in elderly Arab males with low bone mineral density disease.
    Al Attia HM; Jaysundaram K; Saraj F
    Rheumatol Int; 2010 Jan; 30(3):365-7. PubMed ID: 19521700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of obesity on hypogonadism in the andropause.
    Tan RS; Pu SJ
    Int J Androl; 2002 Aug; 25(4):195-201. PubMed ID: 12121568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism.
    Laitinen EM; Hero M; Vaaralahti K; Tommiska J; Raivio T
    Int J Androl; 2012 Aug; 35(4):534-40. PubMed ID: 22248317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gonadal status on body composition and bone mineral density in transfusion-dependent thalassemia.
    Wong P; Fuller PJ; Gillespie MT; Kartsogiannis V; Milat F; Bowden DK; Strauss BJ
    Osteoporos Int; 2014 Feb; 25(2):597-604. PubMed ID: 23903954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific associations between soft tissue body composition and bone mineral density among older adults.
    Kirchengast S; Huber J
    Ann Hum Biol; 2012 May; 39(3):206-13. PubMed ID: 22510104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental body composition transitions in stroke patients: Trunks are different from extremities and strokes are as important as hemiparesis.
    Chang KV; Wu WT; Huang KC; Han DS
    Clin Nutr; 2020 Jun; 39(6):1968-1973. PubMed ID: 31522786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The osteoporotic male: overlooked and undermanaged?
    Madeo B; Zirilli L; Caffagni G; Diazzi C; Sanguanini A; Pignatti E; Carani C; Rochira V
    Clin Interv Aging; 2007; 2(3):305-12. PubMed ID: 18044181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density and body composition in male children with hypogonadism.
    Fintini D; Grossi A; Brufani C; Fiori R; Ubertini G; Pecorelli L; Cappa M
    J Endocrinol Invest; 2009 Jul; 32(7):585-9. PubMed ID: 19535890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadism and male obesity: Focus on unresolved questions.
    Grossmann M
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):11-21. PubMed ID: 29683196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism.
    Medras M; Jankowska EA; Rogucka E
    Andrologia; 2001 Jan; 33(1):47-52. PubMed ID: 11167519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat.
    Tezval M; Serferaz G; Rack T; Kolios L; Sehmisch S; Schmelz U; Tezval H; Stuermer KM; Stuermer EK
    World J Urol; 2011 Aug; 29(4):529-34. PubMed ID: 21298272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study.
    Amin S; Zhang Y; Sawin CT; Evans SR; Hannan MT; Kiel DP; Wilson PW; Felson DT
    Ann Intern Med; 2000 Dec; 133(12):951-63. PubMed ID: 11119396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement.
    Vanderschueren D; Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R
    Endocrinology; 2000 May; 141(5):1642-7. PubMed ID: 10803572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
    Colleluori G; Chen R; Turin CG; Vigevano F; Qualls C; Johnson B; Mediwala S; Villareal DT; Armamento-Villareal R
    Front Endocrinol (Lausanne); 2020; 11():277. PubMed ID: 32499757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.